Login / Signup
Chris T Derk
ORCID
Publication Activity (10 Years)
Years Active: 2018-2024
Publications (10 Years): 3
Top Topics
Patient Reported
Prognostic Factors
Combination Therapy
Systemic Sclerosis
Top Venues
Rheumatology international
BioMed research international
BMC rheumatology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Konstantinos Parperis
,
Egli Costi
,
Sofia Philippou
,
Mohanad Hadi
,
Chris T Derk
>Efficacy of disease-modifying antirheumatic drugs in the treatment of granulomatous mastitis: a systematic review.
Rheumatology international
(2024)
Annemarie Schorpion
,
Max Shenin
,
Robin Neubauer
,
Chris T Derk
A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis.
BMC rheumatology
2 (2018)
Hitomi Hosoya
,
Chris T Derk
Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management.
BioMed research international
2018 (2018)